Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases-Reference-Cited by-同舟云学术

Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases

Published:2010-04 Issue:8 Volume:20 Page:2452-2455
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Fidanze Steve D.,Erickson Scott A.,Wang Gary T.,Mantei Robert,Clark Richard F.,Sorensen Bryan K.,Bamaung Nwe Y.,Kovar Peter,Johnson Eric F.,Swinger Kerren K.,Stewart Kent D.,Zhang Qian,Tucker Lora A.,Pappano William N.,Wilsbacher Julie L.,Wang Jieyi,Sheppard George S.,Bell Randy L.,Davidsen Steven K.,Hubbard Robert D.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference14 articles.

1. Resistance to EGF-R (erbB-1) and VEGF-R modulating agents

2. Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer

3. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts

4. Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation

5. Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy;European Journal of Medicinal Chemistry;2024-10

2. A Glycerol promoted, regioselective synthesis of 6‐aryl substituted Imidazo[2,1‐b]thiazole and imidazo[2,1‐b]‐1,3,4‐thiadiazole through a one‐step domino process under green conditions;ChemistrySelect;2024-03-12

3. Structural and theoretical study of π-stacking interactions in new complexes based on CuCl2 and 3-sulfonamide-substituted imidazo[2,1-b]thiazoles;Journal of Molecular Modeling;2023-04-12

4. Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches;Evidence-Based Complementary and Alternative Medicine;2022-03-20

5. Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors;Bioorganic Chemistry;2021-10